Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity.
Dipannita SantraAmrita BanerjeeSubrata Kr DeHrudayanath ThatoiSmarajit MaitiPublished in: Comparative clinical pathology (2023)
In the last 3 years of the pandemic situation, SARS-CoV-2 caused a significant number of deaths. Infection rates for symptomatic and asymptomatic patients are higher than that for death. Eventually, researchers explored that the major deaths are attributed to several comorbidity factors. The confounding factors and gender-associated infection/death rate are observed globally. This suggests that SARS-CoV-2 selects the human system recognizing the internal comorbid environment. This article explored the influences of hypertension, diabetes, cardiovascular, and renovascular disorders in COVID-19 severity and mortality. Brief mechanistic layouts have been presented here, indicating some of the comorbidity as the critical determinant in the COVID-19 pathogenesis and related mortality.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- end stage renal disease
- type diabetes
- endothelial cells
- newly diagnosed
- ejection fraction
- cardiovascular events
- prognostic factors
- risk factors
- mental health
- staphylococcus aureus
- escherichia coli
- pseudomonas aeruginosa
- biofilm formation
- angiotensin converting enzyme
- induced pluripotent stem cells
- pluripotent stem cells
- patient reported